2016 NEQAS-CC National External Quality Assessment Scheme in Clinical Chemistry - LUNG CENTER OF THE PHILIPPINES

LUNG CENTER OF THE PHILIPPINES
National Reference Laboratory for Clinical Chemistry

    2016 NEQAS-CC
        National
        External
        Quality
        Assessment
        Scheme in
        Clinical Chemistry

Disclaimer
       The presentation slides used for this Orientation
Workshop on 2016 NEQAS-CC Monthly Program, and its
related LCP-NRL- CC documents containing the “RANDOX-
RIQAS 9128 monthly program” are intended ONLY for the
purpose of providing the 2016 National External Quality
Assessment Scheme and are NOT to be considered or taken
as a form of endorsement or advertisement.

       The clinical laboratories are cautioned that this
presentation DOES NOT constitute an offer, advice, invitation,
or recommendation to purchase or subscribe to any of the
RANDOX products.

 To give a brief description of the
                  NEQAS-CC Program for 2016

                 To update the clinical laboratory
                  participants about the changes in
                  the 2016 NEQASS-CC Program
2016 NEQAS-CC
Objectives       To assist clinical laboratory
                  participants on how RIQAS online
                  is used with regards to:
                      Registration
                      Configuration
                      Submission of Results On-line
                      Troubleshooting

LCP-NRL-CC
ORGANIZATIONAL
  STRUCTURE

2016 NEQAS-CC
  Monthly Program

2016 NEQAS-CC Monthly Program

                 PROCESS FLOW
  NEQAS           Registration of           Contract and
  Bidding         Participants             NEQAS sample
  Process           (April-May: DM            orders
  (Jan-Mar )           deadline)                 (June)
SUBMISSION
  RANDOX)
 of Monthly          Start of the           ORIENTATION
   Results           NEQAS-CC                    OF
 via on-line          Program               PARTICIPANTS
 (*July-June)      (August: Testing of        (July-August)
www.riqas.net)        the samples)

STATISTICAL         DISCLOSURE                 SELF-
 ANALYSIS        of Monthly and End         EVALUATION
(RIQAS 9128)      of Cycle NEQAS-             -Review of reports
  By Randox         CC Reports to            -Perform corrective
                     Participants              action if needed

2016 NEQAS-CC
  Monthly Program

    Changes

Changes:
                    Cycle
                    Delivery of Samples
2016 NEQAS-CC
 Monthly Program
                    Schedule of Deadlines

  Randox-           Reports and
 RIQAS9128
                     Guidelines
                    Certification

 One year cycle =
                12 monthly Cycle

         RIQAS 9128 consists of:
Cycle     Cycle 13B –
             July to December 2016
          Cycle 14 A –
            January to June 2017

2 batches:

Delivery    1st batch of delivery
                Cycle 13B
   of          July-August 2016
Samples     2nd batch of delivery
                Cycle 14A
              November 2016

Stability-
            Lyophilized
           Once reconstituted,
             viable for 2 days
  2016
NEQAS-CC
Samples

 Deadline is last Monday
                          of the Month
               “Late result” will NOT be
Submission      accepted and included in the
 of Results     statistical data, an email will
                be sent giving the average of
 Schedule       the comparator group instead
    of
 Deadlines     Please DO NOT beat the
                deadline mentioned so as to
                have an allowance for any
                changes

 Corrected results may
                be accepted, up to 4
                weeks after the final date,
Submission      but ONLY for
                transcription errors
 of Results
               A lab wishing to submit a
                corrected result must
 Schedule
                complete a request form
    of
 Deadlines      and submit the analyser
                print out as an evidence
                that a transcription error
                was made

 All results are processed by
                RIQAS within 24 – 72 hours
                of the Final Date deadline
 Reports       Based on Standard
   and          Deviation
Guidelines  Participants can quickly
                 appraise their own
                 performance, in comparison
                 with that of other laboratory
                 participants

Reports
   and
Guidelines

Text Section:        Levey Jennings Chart:
Contains all the        Shows performance
   statistical               with time

 information           Target Scoring Chart:
                             Provides a
                         visualization of a
                        Lab’s Target Scores
     Histogram:          % Deviation by
Provides a method        Sample Chart:
  and instrument        Helps to identify
                      trends and shifts in
   comparison
                          performance
  Multi Method Stat     % Deviation by
       Section:       Concentration Chart:
Enables assessment      Provides a rapid
of the performance       assessment of
  of each method         concentration
                         related biases

Solid vertical line:
Change in registration
     Method
     Instrument
     Reagent supplier
     Unit of
   measurement

Text Section

  N: Number of results used to generate the mean
  Mean: The average result, based on a consensus
  CV%: Coefficient of Variation
  Um: Uncertainty of the Mean
  SDPA: Standard Deviation for Performance
  Assessment
  Exc.: Excluded results (outliers)

This contains a summary of
    your performance

―Your Result
― Mean for Comparison
― Indicators of
Performance
      Standard Deviation
   Index (SDI)
      Target Score (TS)
      % Deviation (%DEV)
      Various Running
   Mean Indices (RM)

Histogram:
Provides group comparison

                All Method Group

                   Your Method Group
                      Your Instrument Group

                       Your Result

Target Score Chart

                              Excellent

                              Good

                              Acceptable

                              Need for
                              improvement

                              Unacceptable
Target Score

               Sample
               Number

 This provides a numerical index of
           performance and allows participants
           to assess performance at a glance

Target
          Target Score (TS) Interpretation:
              101-120     Excellent
Score          71-100     Good
               51-70      Acceptable
               41-50      Needs Improvement
               10-40      Unacceptable

a black dot within the white section
                     represents results within the acceptable
                              limits of performance
              The black dots represent the % Dev of each reported
                                     result

 The white circles represent the
RM%Dev at each time point, and
 will help to identify any distinct
               trends
                       And a black dot within one of the red sections
                         represents results outside the acceptable
                                    limits of performance

% Deviation by Concentration Chart:

    Current sample
    indicated by the square

                       The circles represent previous
                       samples at different concentrations

 check first the Summary page
             (located at the back of the RIQAS
             report) to assess your performance
             for the most recent sample

            Look for red triangle ( ),
            focus your investigations on these
             analytes
Remember
            The triangle will only appear when
             all limits are exceeded:
                     SDI             >2
                   Target Score < 50
                    % Deviation > Acceptable
                         limits of performance

For the LJ and Target score charts:
            Shading indicates performance,
            The lighter the shading, the
             more accurate the results
Remember
            % Deviation, which indicates by
             what percentage the
             laboratory’s result deviates from
             the mean for comparison

Requirements:
Certificate of    at least
Participation  four (4) sample results
   to the       for cycle 13B, and
2016 NEQAS  four (4) sample results
                  for cycle 14A

Certificate of
Participation    At least six (6) out of
 on Randox-      the 12 samples
    Riqas

 AO 2007-0027:
         Secondary Category : Routine
         Clinical Chem – Gluc, BUN, UA,
         Crea, Total Cholesterol
          Please do not beat the
Remember
            deadline given so as to have
            allowance for any changes
          Always update your e-mail
            account and the contact
            person

Summary

 Cycle     ONE year, 12 mos (Cycle 13B and Cycle 14A)
 Delivery of Samples     2 batches
     (6 samples / kit) (July- Dec 2016; Jan- June 2017)
 RIQAS Online- Registration, Configuration
     Submission and Reports
 Submission of Results-Deadline is last Monday of the
     Month. Late submission will not be accepted
 Result Format and Guidelines new format,
         3 indicators: SDI, TS and %DEV
 Certificates - COP NEQAS: at least 4 samples per
     “cycle” (13B and 14A)
 COP Riqas by Randox: at least 6 of 12 samples

For Queries about the 2016 NEQAS
       Program: email us at

  lcp_nrl_cc@yahoo.com
      call us at (02) 9246101 loc 388

  ANNOUNCEMENT:
    For NRL updates and notices:
          lcp.gov.ph

For RIQAS 9128 Service Issues,
       please contact:

   Marsman Drysdale
    Hotline number
    (0917) 598-8534